Predicate |
Object |
contentType |
Comment|Journal Article |
endingPage |
99 |
issn |
1531-0035 |
issueIdentifier |
1 |
pageRange |
87-99 |
publicationName |
Perspectives in Vascular Surgery and Endovascular Therapy |
startingPage |
87 |
bibliographicCitation |
Sobel M. Commentary. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Perspect Vasc Surg Endovasc Ther. 2007 Mar;19(1):87–9. doi: 10.1177/1531003507299489. PMID: 17437989. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_04e9fdc367b631351e622e39cd4544a4 |
date |
2007-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://pubmed.ncbi.nlm.nih.gov/17437989 https://doi.org/10.1177/1531003507299489 |
isPartOf |
https://portal.issn.org/resource/ISSN/1531-0035 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32334 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ |
title |
Commentary. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7217 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3108 |